Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors
- PMID: 28860318
- DOI: 10.1161/CIRCRESAHA.117.308903
Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors
Abstract
Current global health policy goals include a 25% reduction in premature mortality from noncommunicable diseases by 2025. In this 2-part review, we provide an overview of the current epidemiological data on cardiovascular diseases (CVD), its risk factors, and describe strategies aimed at reducing its burden. In part 1, we examine the global epidemiology of cardiac conditions that have the greatest impact on CVD mortality; the predominant risk factors; and the impact of upstream, societal health determinants (eg, environmental factors, health policy, and health systems) on CVD. Although age-standardized mortality from CVD has decreased in many regions of the world, the absolute number of deaths continues to increase, with the majority now occurring in middle- and low-income countries. It is evident that multiple factors are causally related to CVD, including traditional individual level risk factors (mainly tobacco use, lipids, and elevated blood pressure) and societal level health determinants (eg, health systems, health policies, and barriers to CVD prevention and care). Both individual and societal risk factors vary considerably between different regions of the world and economic settings. However, reliable data to estimate CVD burden are lacking in many regions of the world, which hampers the establishment of nationwide prevention and management strategies. A 25% reduction in premature CVD mortality globally is feasible but will require better implementation of evidence-based policies (particularly tobacco control) and integrated health systems strategies that improve CVD prevention and management. In addition, there is a need for better health information to monitor progress and guide health policy decisions.
Keywords: blood pressure; cardiovascular diseases; epidemiology; risk factors; tobacco.
© 2017 American Heart Association, Inc.
Similar articles
-
Challenges for the management of hypertension in low-resource settings.Ethn Dis. 2003 Summer;13(2 Suppl 2):S67-70. Ethn Dis. 2003. PMID: 13677416 Review.
-
Estimates of global and regional premature cardiovascular mortality in 2025.Circulation. 2015 Sep 29;132(13):1270-82. doi: 10.1161/CIRCULATIONAHA.115.016021. Circulation. 2015. PMID: 26408271
-
Cardiovascular Diseases in India: Current Epidemiology and Future Directions.Circulation. 2016 Apr 19;133(16):1605-20. doi: 10.1161/CIRCULATIONAHA.114.008729. Circulation. 2016. PMID: 27142605 Review.
-
The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):10-4. doi: 10.1016/j.pcad.2010.01.001. Prog Cardiovasc Dis. 2010. PMID: 20620420
-
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.Eur Heart J. 2010 Mar;31(6):642-8. doi: 10.1093/eurheartj/ehq030. Epub 2010 Feb 22. Eur Heart J. 2010. PMID: 20176800 Review.
Cited by
-
Hypertrophic Cardiomyopathy in Saudi Arabia: A Systematic Review of the Epidemiological, Clinical, and Imaging Features.Curr Cardiol Rev. 2023;19(2):e250822208003. doi: 10.2174/1573403X18666220825153725. Curr Cardiol Rev. 2023. PMID: 36028969 Free PMC article.
-
Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion.Acta Cir Bras. 2021 May 7;36(3):e360306. doi: 10.1590/ACB360306. eCollection 2021. Acta Cir Bras. 2021. PMID: 33978062 Free PMC article.
-
The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: Findings from behavioral risk factor surveillance system, 2020.Front Cardiovasc Med. 2022 Oct 6;9:909383. doi: 10.3389/fcvm.2022.909383. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277785 Free PMC article.
-
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.Signal Transduct Target Ther. 2022 Sep 16;7(1):324. doi: 10.1038/s41392-022-01178-6. Signal Transduct Target Ther. 2022. PMID: 36114195 Free PMC article. Review.
-
Melatonin Use during Pregnancy and Lactation Complicated by Oxidative Stress: Focus on Offspring's Cardiovascular-Kidney-Metabolic Health in Animal Models.Antioxidants (Basel). 2024 Feb 12;13(2):226. doi: 10.3390/antiox13020226. Antioxidants (Basel). 2024. PMID: 38397824 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources